Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Fgfr3 Inhibitor Compounds
Abstract: The present invention provides compounds of the formula:, for use in the treatment of systemic sclerosis, fibrosis (e.g. pulmonary fibrosis), achondroplasia, thanatophoric dysplasia (e.g. type I), severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), muenke syndrome or cancer.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
11 September 2023
Publication Number
50/2023
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Applicants
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285
Inventors
1. ABRAHAM, Adedoyin David
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
2. BUME, Desta Doro
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
3. CONDROSKI, Kevin Ronald
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
4. DILGER, Andrew Karl
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
5. HAZLITT, Robert Alan
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
6. KERCHER, Timothy Scott
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
7. METCALF, Andrew Terrance
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
8. URKALAN, Kaveri Balan
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
9. WALLS, Shane Michael
c/o Eli Lilly And Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202317061092-STATEMENT OF UNDERTAKING (FORM 3) [11-09-2023(online)].pdf | 2023-09-11 |
| 2 | 202317061092-REQUEST FOR EXAMINATION (FORM-18) [11-09-2023(online)].pdf | 2023-09-11 |
| 3 | 202317061092-POWER OF AUTHORITY [11-09-2023(online)].pdf | 2023-09-11 |
| 4 | 202317061092-FORM 18 [11-09-2023(online)].pdf | 2023-09-11 |
| 5 | 202317061092-FORM 1 [11-09-2023(online)].pdf | 2023-09-11 |
| 6 | 202317061092-DECLARATION OF INVENTORSHIP (FORM 5) [11-09-2023(online)].pdf | 2023-09-11 |
| 7 | 202317061092-COMPLETE SPECIFICATION [11-09-2023(online)].pdf | 2023-09-11 |
| 8 | 202317061092-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [11-09-2023(online)].pdf | 2023-09-11 |
| 9 | 202317061092-FORM 3 [04-03-2024(online)].pdf | 2024-03-04 |
| 10 | 202317061092-Proof of Right [07-03-2024(online)].pdf | 2024-03-07 |
| 11 | 202317061092-FER.pdf | 2025-07-02 |
| 12 | 202317061092-FORM 3 [29-08-2025(online)].pdf | 2025-08-29 |
Search Strategy
| 1 | 202317061092_SearchStrategyNew_E_SearchstartogyE_30-06-2025.pdf |